The Gold Medi Test Plus BZO Urine Rapid Test is designed for the rapid and qualitative detection and identification of benzodiazepine metabolites in urine. It is intended solely for forensic and in vitro diagnostic use.
This test operates based on the immunochromatography method and has a sensitivity of 300 ng/mL. This test is for rapid screening only and provides a preliminary result. A more specific alternative method should be used to confirm initial results; High-Performance Liquid Chromatography (HPLC) is the preferred method for this purpose. If the test result is positive, clinical examinations are necessary to determine substance abuse.
The Rapid Benzodiazepine Test is a quick and qualitative assay for detecting benzodiazepine metabolites in urine. This test is performed using an immunochromatographic method and has a sensitivity of 300 ng/mL. The purpose of this test is the preliminary detection of benzodiazepine use, and its results should be confirmed with more specialized tests.
This test is used to identify the use of benzodiazepines (such as diazepam, alprazolam). Benzodiazepines are medications commonly prescribed for treating anxiety, sleep disorders, and epilepsy. This test is typically used when there’s a need to diagnose the abuse of these medications.
To use this test, a urine sample is collected, and the test strip is placed into it. Results are visible after a few minutes. A line in the control region indicates the test is working correctly, and additional lines indicate positive or negative results.
The rapid benzodiazepine test is designed for in vitro diagnostic use only.
If the result is positive, clinical tests should be performed to confirm substance abuse.
Long-term or high-dose use of benzodiazepines can lead to addiction, and abrupt discontinuation may cause physical and psychological withdrawal symptoms.
